Collaboration on artificial intelligence: Improving lung and breast cancer care through AI-driven precision diagnostics
Oslo University Hospital and Karolinska Institutet (KI) have entered a postdoctoral partnership with AstraZeneca. The aim is to improve lung and breast cancer care through AI-driven precision diagnostics.
In Oslo, we are welcoming Anna Christina Garvert as a postdoc in lung cancer, and Francisco Peña has been selected and started at KI working on breast cancer. They will be developing AI-based tools for precision medicine in cancer, utilizing existing diagnostic and clinical data to enhance patient outcomes.